Expert Opin Biol Ther. 2020 May 14. doi: 10.1080/14712598.2020.1770222. [Epub ahead of print]
Tocilizumab: From the Rheumatology Practice to the Fight Against COVID-19, a virus infection with multiple faces.


Gonz?lez-Gay MA1,2,3, Mayo J4, Casta?eda S5, Cifri?n JM6, Hern?ndez-Rodr?guez J7.

Author information




KEYWORDS:

COVID-19; anakinra; chimeric antigen receptor (CAR) T cell‐induced cytokine release syndrome; colchicine; coronavirus; inflammation; interleukin-6; macrophage activation syndrome; tocilizumab


PMID:32406282DOI:10.1080/14712598.2020.1770222